ICD-10-CM Billable Code

M06.82

Other specified rheumatoid arthritis, elbow

Clinical Classification Guidelines

Medical Intelligence & Overview

Other specified rheumatoid arthritis of the elbow, classified under ICD-10 code M06.82, is a form of rheumatoid arthritis that specifically affects the elbow joint. Rheumatoid arthritis (RA) is a chronic autoimmune disease where the immune system mistakenly attacks the body's own joints, leading to inflammation, pain, and potential joint damage. The term 'other specified' indicates that the condition does not fit entirely into typical RA categories but still involves rheumatoid pathology in the elbow joint. This condition can significantly impair daily activities, especially those requiring elbow movement, and may progress if not adequately managed.

Causes & Symptoms

Clinical Causes: Genetic predisposition that increases the likelihood of autoimmune responses. Environmental factors, such as exposure to tobacco smoke or certain infections, that may trigger immune system activity. Hormonal influences, particularly in women, which may affect disease onset and progression. Autoimmune mechanism where the immune system attacks synovial tissue in the elbow joint. Unknown factors that may contribute to disease development.

Key Symptoms: Persistent pain in the elbow, especially during movement or after periods of inactivity. Swelling and tenderness around the elbow joint. Stiffness, particularly in the morning or after periods of rest. Reduced range of motion, making it difficult to fully extend or flex the elbow. Warmth and redness over the affected joint. Fatigue and general feelings of illness that often accompany RA flare-ups. Possible deformities if the disease progresses and joint damage occurs.

Diagnostic & Treatment

Diagnosis Path: Diagnosing rheumatoid arthritis affecting the elbow involves a combination of medical history review, physical examination, and specialized tests. Healthcare providers may use the following approaches: - Physical assessment to evaluate joint swelling, tenderness, and range of motion. - Blood tests to detect markers of inflammation (like ESR and CRP), rheumatoid factor (RF), and anti-CCP antibodies. - Imaging studies such as X-rays, ultrasounds, or MRIs to assess joint damage, inflammation, and other changes characteristic of RA. - Synovial fluid analysis, if joint fluid samples are obtained, to exclude other causes like infection or gout.

Treatment Protocols: Management of other specified rheumatoid arthritis of the elbow aims to reduce inflammation, alleviate pain, prevent joint damage, and maintain function. Treatment options include: - Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to slow disease progression. - Nonsteroidal anti-inflammatory drugs (NSAIDs) to control pain and inflammation. - Corticosteroids, administered orally or via injections, for quick inflammation relief. - Biological agents that target specific immune pathways involved in RA. - Physical therapy to improve joint flexibility and muscle strength. - Occupational therapy to support daily activities and adapt to joint limitations. - Sometimes, surgical interventions like joint repair or replacement are considered if joint damage is severe. Regular monitoring and a multidisciplinary approach are essential for optimal management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M06.82 a billable ICD-10 code?
Yes, M06.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M06.82?
Clinical documentation must specify the nature of Other specified rheumatoid arthritis, elbow and any associated comorbidities for accurate reporting.

Cite this Clinical Reference